A study concludes that chemotherapy agents used in the treatment of cancer were less effective against human breast cancer cells when exposed to low levels of bisphenol A, leading to suspicions that the chemical, found in many plastic products, could interfere with treatment. The Food and Drug Administration, which has declared BPA to be safe, scheduled an advisory panel meeting to discuss the issue on Oct. 31.

Related Summaries